<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02254980</url>
  </required_header>
  <id_info>
    <org_study_id>E1-H</org_study_id>
    <nct_id>NCT02254980</nct_id>
  </id_info>
  <brief_title>Migration and Head Penetration of Vitamin-E Diffused Cemented Polyethylene Cup in Total Hip Arthroplasty</brief_title>
  <acronym>E1-hip</acronym>
  <official_title>Migration and Head Penetration of Vitamin-E Diffused Cemented Polyethylene Cup Compared to Standard Cemented Cup in Total Hip Arthroplasty. A Randomized, Single-blinded, Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danderyd Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Danderyd Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In vitro, Vitamin-E diffused, highly cross-linked polyethylene (PE) have been shown to have
      superior wear resistance and improved mechanical properties as compared to that of standard
      highly cross-linked PE. There are as of yet no published studies with vitamin-E diffused PE
      although several trials are ongoing. All of these trials use uncemented acetabular cups
      intended for biological fixation. In many countries the standard fixation method for the
      acetabular component is bone-cement. The Vitamin-E used in implants is alfa-tocopherol, a
      lipid-soluble antioxidant with oily consistency; theoretically affecting cemented fixation
      when used in acetabular components. The aim of the study is to compare migration, linear wear
      and clinical results between two types of cemented acetabular cups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">October 2026</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cup migration</measure>
    <time_frame>2 years</time_frame>
    <description>The primary outcome measure is migration of the cup at 2 years measured with radiostereometry (RSA) as proximal migration.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Linear wear</measure>
    <time_frame>2 years</time_frame>
    <description>Linear head penetration measured with RSA at 2 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Linear wear</measure>
    <time_frame>4 years</time_frame>
    <description>Linear head penetration measured with RSA at 4 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osteolysis</measure>
    <time_frame>10 years</time_frame>
    <description>Development of radiolucent lines between bone and cement around the cup.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Osteolysis</measure>
    <time_frame>2 years</time_frame>
    <description>Development of radiolucent lines between bone and cement around the cup.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome</measure>
    <time_frame>2 years</time_frame>
    <description>Hip function measured with Harris hip score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>10 years</time_frame>
    <description>All hip-related complications and revision of implants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cup migration total</measure>
    <time_frame>2 years</time_frame>
    <description>Migration of the cup at 2 years measured with radiostereometry (RSA) as maximum total point motion (MTPM).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Total Hip Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Vitamin-E group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin-E diffused polyethylene</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard polyethylene</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vitamin-E diffused polyethylene acetabular component</intervention_name>
    <description>Patients will undergo total hip arthroplasty using a cemented acetabular component diffused with Vitamin-E</description>
    <arm_group_label>Vitamin-E group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard polyethylene acetabular component</intervention_name>
    <description>Patients will undergo total hip arthroplasty using a standard cemented acetabular component</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary osteoarthritis of the hip

          -  Willingness and ability to follow study-protocol

        Exclusion Criteria:

          -  Inflammatory arthritis or secondary osteoarthritis.

          -  Type C (stove pipe) femur

          -  Abnormal femoral or pelvic anatomy after hip dysplasia, not suitable for implantation
             of components

          -  Treatment with bisphosphonates, cortisol or cytostatic drugs 6 months prior to surgery

          -  Ongoing oestrogen treatment

          -  Not suited for the study for other reason (surgeons preference)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Olof Sköldenberg, MD, PhD</last_name>
    <phone>+46700891253</phone>
    <email>olof.skoldenberg@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Orthopaedic department, Danderyd Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>18288</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene Sjöö, RN</last_name>
      <phone>+46812355138</phone>
      <email>helene.sjoo@ds.se</email>
    </contact>
    <investigator>
      <last_name>Olof G Sköldenberg, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2014</study_first_submitted>
  <study_first_submitted_qc>October 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2014</study_first_posted>
  <last_update_submitted>August 29, 2016</last_update_submitted>
  <last_update_submitted_qc>August 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Danderyd Hospital</investigator_affiliation>
    <investigator_full_name>Olof Skoldenberg</investigator_full_name>
    <investigator_title>Consultant orthopedic surgeon</investigator_title>
  </responsible_party>
  <keyword>Total hip arthroplasty</keyword>
  <keyword>Cemented acetabular cup</keyword>
  <keyword>Vitamin-E</keyword>
  <keyword>Radiostereometry</keyword>
  <keyword>Fixation of cemented acetabular component in total hip arthroplasty</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
    <mesh_term>Tocopherols</mesh_term>
    <mesh_term>Tocotrienols</mesh_term>
    <mesh_term>alpha-Tocopherol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

